ClinicalTrials.govpublic full text
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
colorectal neoplasms, nsabp, bevacizumab, capecitabine, oxaliplatin, irinotecan, rectal cancer, colon cancer, colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907287
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.